Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,561–2,568 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Matinas Biopharma Holdings Inc. MAT2203 - (ORALTO) Invasive aspergillosis Phase 3 Withdrawn oral Anti-Fungal
Matinas Biopharma Holdings Inc. MAT9001 - (ENHANCE-IT) Severe hypertriglyceridemia Phase 2 Trial Discontinued Oral Endocrinology
Maze Therapeutics Inc. MZE829 APOL1 kidney disease Phase 2 Trial Planned Oral Genetic Disorder
Maze Therapeutics Inc. MZE782 Phenylketonuria (PKU) Phase 2 Trial Planned oral Genetic Disorder
Maze Therapeutics Inc. MZE782 Chronic Kidney Disease (CKD) Phase 2 Trial Planned oral N/A
MBX Biosciences Inc. Canvuparatide (MBX 2109) - (Avail) Hypoparathyroidism Phase 2 Data Released Subcutaneous Endocrinology
Medicenna Therapeutics Corp. MDNA55 (bizaxofusp) - (LIGHT) Recurrent Glioblastoma (GBM) Phase 2b Data Released Intratumoral Oncology
MediciNova Inc. Ibudilast (MN-166) - (COMBAT-ALS) Amyotrophic lateral sclerosis (ALS) Phase 2/3 Enrollment Conclusion Oral Neurology